Sinex

Active Ingredient(s): Phenylephrine
Category: Allergies, Cough & Cold



Sinex Overview

Vicks Sinex is a brand of topical nasal decongestant spray produced by Vicks, a division of Procter & Gamble. The active ingredient contained in the Sinex nasal spray is Oxymetazoline which acts to relieve blocked nasal passages. The recommended dosage is 2–3 sprays in each nostril every 10–12 hours, though users should check the packaging for the specific product purchased.[1] Excessive use of this product could lead to a dependency on it whereby the nasal pas...

Read more Sinex Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Vicks_Sinex

Recent Sinex Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Phenylephrine
  • Cream: 0.25%
  • Drops: 0.5%, 1%
  • Injection: 1%, 10mg/ml
  • Ointment: 0.25%
  • Solution: 0.125%, 0.16%, 0.25%, 0.5%, 1%, 10%, 100mg/10ml (10mg/ml), 10mg/ml (10mg/ml), 2.5%, 50mg/5ml (10mg/ml)
  • Spray: 0.25%, 0.5%, 1%
  • Spray, Metered: 0.25%, 0.5%, 1%
  • Suppository: 0.25%
  • Suspension: 7.5mg/5ml
  • Tablet: 10mg
  • Tablet, Chewable: 10mg
  • Tablet, Orally Disintegrated: 10mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Sinex: (2 results)

Sorted by National Drug Code
  • 37000-508 Sinex Oral Capsule, Liquid Filled by The Procter & Gamble Manufacturing Company
  • 37000-509 Sinex Kit by The Procter & Gamble Manufacturing Company

Other drugs which contain Phenylephrine or a similar ingredient: (187 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA